Move over Appen: A new artificial intelligence stock to list on the ASX

This technology could save some of the 9 million lives lost each year to coronary artery disease.

| More on:
A medical specialist holds a red heart connected via technology and artificial intelligence (AI)

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Appen Ltd (ASX: APX) is the most prominent technology company on the ASX involved in artificial intelligence (AI).

Its shareholders have suffered immensely in recent times, with the stock dropping more than 65% over the past 12 months. But even with that calamity, Appen shares have quadrupled in the last 5 years.

And it has gained more than 1,668% since listing in January 2015.

So if you're interested in getting in from the ground level on a new AI player, there is one such company listing this month on the ASX.

Heart disease will only increase with an ageing population

Perth's Artrya Limited (ASX: AYA) has just closed its initial public offer, with its shares due to commence general trading on the ASX on 26 November.

The company's technology aims to automate the diagnosis of coronary artery heart disease, which can cause heart attacks.

Co-founder and managing director John Barrington said there is growing demand for improved detection of coronary artery disease.

"With 9 million people dying from the disease each year globally, the pressure on health systems is already substantial, and it's only going to increase over the next few decades with ageing populations," he said.

"This float will assist the company in its next stage in expansion."

During the IPO, shares were offered for $1.35 each to raise $40 million and give Artrya a market valuation of $105.45 million.

According to the company, it has received $19 million of funding over the past 2 years from both investors and government research funds.

The Motley Fool has enquired with Artrya to confirm the progress of the IPO.

'No warning signs of a heart attack'

Artrya's flagship cloud software suite is called Salix, which non-invasively detects the presence of "vulnerable plaque" in a patient's arteries in about 15 minutes.

Such plaque is liable to rupture and cause heart attacks.

The technology was developed in conjunction with expertise from the University of Western Australia, the Harry Perkins Institute of Medical Research, and the Ottawa Heart Institute.

An "unrestricted launch" across Australia is scheduled for early in the new year while the IPO money will be used to take the technology overseas after that.

"Coronary artery disease affects an estimated 126 million people worldwide," said Artrya chair Bernie Ridgeway.

"Of those, the majority have no warning signs of a heart attack. As the prevalence of CAD rises due to an ageing population, global health systems will have to deal with more CAD cases."

He added that Salix is expected to disrupt the international market for Coronary Computed Tomography Angiography (CCTA) scans and Invasive Coronary Angiogram (ICA) procedures.

"An estimated 20 million cardiac CT scans are expected to be performed in both North America and Europe alone by 2025," said Ridgeway.

"By addressing current limitations in diagnostic reporting for CAD, Salix has a valuable first-mover advantage."

Salix was placed on the Australian Register of Therapeutic Goods (ARTG) as a Class 1 medical device in November last year.

Artrya is pursuing a subscription model for commercialisation of the software.

"This model will help Artrya penetrate the global CCTA and ICA markets because healthcare providers pay no upfront costs to use Salix," Ridegeway said.

"Artrya believes the software-as-a-service model could deliver annuity revenue and profitable margins for the company."

Motley Fool contributor Tony Yoo owns shares of Appen Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Appen Ltd. The Motley Fool Australia owns shares of and has recommended Appen Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

A woman is excited as she reads the latest rumour on her phone.
Technology Shares

How is the DroneShield share price avoiding the market weakness and jumping 13%?

This tech stock reported stunning quarterly growth.

Read more »

A man looking at his laptop and thinking.
Technology Shares

NextDC share price tumbles as trading resumes amid $1.32 billion cap raising

ASX 200 investors are bidding down the NextDc share price on Monday.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Technology Shares

Guess which hot ASX tech stock Bell Potter just upgraded and is tipping to rise 28%

The broker thinks recent weakness has created an opportunity for investors.

Read more »

Data Centre Technology
Technology Shares

Own NextDC shares? Here's why the company is spruiking nuclear power

NextDC announced a $1.32 billion capital raising to expand its data centre operations.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Technology Shares

Cettire share price jumps 13% on explosive Q3 sales growth

This online retailer delivered strong revenue growth in the third quarter. But what about its earnings?

Read more »

Five happy friends on their phones.
Technology Shares

Is Life360's soaring share price still 20% undervalued?

Here's what one leading broker is saying about this hot stock.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Technology Shares

One ASX share to buy right now after the US market pullback

With US markets retracing overnight, I think this ASX share is one to buy right now.

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Technology Shares

Up 16% in 2024! Are ASX tech shares now overvalued?

Could it be time to cash in on recent big winners in the share market?

Read more »